Skip to main content
. 2022 Jul 6;2022:1817339. doi: 10.1155/2022/1817339

Figure 4.

Figure 4

Evaluation of the TP53 mutational status-associated signature in training and validation datasets, as well as in clinical specimens. (a–c) Risk score, survival status, K–M curve, and ROC curve in TCGA; (d–f) ucec_tcga_pan_can_atlas_2018; (g–i) ucec_tcga_pub dataset; (j–l) clinical specimens.